Skip to main content
Clinical Trials/EUCTR2021-002824-19-BE
EUCTR2021-002824-19-BEActive, not recruitingPhase 1

Study of the hypnotic and anti-nociceptive components of Magnesium using Electroencephalogram Spectral Entropy and pupillometry during total intravenous general anesthesia : a randomized double-blind placebo-controlled clinical trial

CHU de Liège0 sites20 target enrollmentStarted: July 28, 2021Last updated:
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Patients aged 18–95 years, American Society of Anesthesiologists Physical Status I–III, scheduled for elective thyroidectomy at CHU of Liège.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 15
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 5

Exclusion Criteria

  • Participants will be excluded if they had a heart failure with left ventricular ejection fraction < 35%, renal insufficiency (creatinine clearance < 40 mL/min), neuromuscular diseases or atrioventricular block.

Investigators

Sponsor
CHU de Liège

Similar Trials